Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

SHE:001367 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,034	943.75	247.19	205.26	139.91
Trading Asset Securities	-	-	-	0.74	-
Cash & Short-Term Investments	1,034	943.75	247.19	206	139.91
Cash Growth	9.61%	281.79%	19.99%	47.24%	1.68%
Accounts Receivable	89.2	57.73	47.3	44.61	39.62
Other Receivables	15.17	14.94	0.04	2.81	0.35
Receivables	104.38	72.67	47.34	47.42	39.97
Inventory	115.48	159.31	142.65	104.94	86.18
Other Current Assets	3.29	2.25	9.01	2.39	0.89
Total Current Assets	1,258	1,178	446.19	360.75	266.94
Property, Plant & Equipment	201.51	134.9	85.64	85.89	64.54
Other Intangible Assets	20.14	19.78	19.74	20.26	18.15
Long-Term Deferred Tax Assets	-	-	1.79	1.37	0.87
Long-Term Deferred Charges	0.27	0.26	1.8	3.27	5
Other Long-Term Assets	6.45	8.04	10.45	5.76	7.89
Total Assets	1,486	1,341	565.6	477.31	363.39
Accounts Payable	52.16	46.55	34.94	56.28	31.43
Accrued Expenses	18.21	15.65	14.73	14.97	13.64
Current Portion of Leases	1.14	0.07	0.78	0.75	-
Current Income Taxes Payable	9.58	6.05	21.61	11.33	9.73
Current Unearned Revenue	7.92	4.16	7.08	9.49	5.71
Other Current Liabilities	33.04	6.3	4.26	10.04	16.61
Total Current Liabilities	122.04	78.77	83.4	102.86	77.13
Long-Term Leases	6.98	0.1	-	0.78	-
Long-Term Unearned Revenue	5.39	5.85	6.22	5.59	3.08
Long-Term Deferred Tax Liabilities	7.43	6.89	6.7	6.78	4.22
Other Long-Term Liabilities	-	-	0.24	-	-
Total Liabilities	141.84	91.62	96.57	116.02	84.42
Common Stock	102.65	68	51	51	51
Additional Paid-In Capital	759.97	763.02	104.3	104.3	104.3
Retained Earnings	505.63	417.07	312.4	204.88	122.31
Treasury Stock	-25.46	-	-	-	-
Comprehensive Income & Other	1.37	1.25	1.33	1.11	1.35
Shareholders' Equity	1,344	1,249	469.03	361.29	278.96
Total Liabilities & Equity	1,486	1,341	565.6	477.31	363.39
Total Debt	8.12	0.17	0.78	1.53	-
Net Cash (Debt)	1,026	943.59	246.41	204.47	139.91
Net Cash Growth	8.77%	282.94%	20.51%	46.15%	1.68%
Net Cash Per Share	10.13	10.19	3.27	2.71	1.85
Filing Date Shares Outstanding	100.64	100.64	75.48	75.48	75.48
Total Common Shares Outstanding	100.64	100.64	75.48	75.48	75.48
Working Capital	1,136	1,099	362.78	257.89	189.82
Book Value Per Share	13.36	12.41	6.21	4.79	3.70
Tangible Book Value	1,324	1,230	449.29	341.03	260.82
Tangible Book Value Per Share	13.16	12.22	5.95	4.52	3.46
Buildings	59.66	55.1	52.99	53.03	38.13
Machinery	149.06	123.92	107.08	106.47	88.32
Construction In Progress	73.59	48.05	8.41	0.93	6.19

Updated Oct 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.